M8429
D-マンニトール
meets EP, FCC, USP testing specifications
別名:
マンニット
ログインで組織・契約価格をご覧ください。
サイズを選択してください
この商品について
実験式（ヒル表記法）:
C6H14O6
CAS番号:
分子量:
182.17
UNSPSC Code:
12352207
NACRES:
NA.71
PubChem Substance ID:
EC Number:
200-711-8
Beilstein/REAXYS Number:
1721898
MDL number:
製品名
D-マンニトール, meets EP, FCC, USP testing specifications
InChI key
FBPFZTCFMRRESA-KVTDHHQDSA-N
InChI
1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4-,5-,6-/m1/s1
SMILES string
OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
agency
meets EP testing specifications
meets USP testing specifications
reg. compliance
meets FCC testing specifications
assay
≥96.0%
form
powder
quality
meets EP, FCC, USP testing specifications
impurities
<1 ppm Lead
color
white
useful pH range
5.0-6.5 (25 °C, 182 g/L)
mp
167-170 °C (lit.)
solubility
water: soluble 182 g/L at 20 °C (68 °F)
cation traces
Ni: <1 ppm
Quality Level
類似した製品をお探しですか？ 訪問 製品比較ガイド
関連するカテゴリー
Application
- モデル炭酸飲料中の甘味アロマ化合物の放出に及ぼす低濃度ポリオールの影響：この研究では、ポリオールの中でも特に D-マンニトールが飲料中の甘味アロマ化合物の放出に与える影響を検討し、食品化学における風味の向上と安定性に関する知見を得ました（Barba et al., 2024）。
Biochem/physiol Actions
糖アルコールの甘味物質です。甘味阻害試験に用いられます。
保管分類
11 - Combustible Solids
wgk
WGK 1
ppe
Eyeshields, Gloves, type N95 (US)
Maria Badal Tejedor et al.
International journal of pharmaceutics, 486(1-2), 315-323 (2015-04-07)
Tablets are the most convenient form for drug administration. However, despite the ease of manufacturing problems such as powder adhesion occur during the production process. This study presents surface and structural characterization of tablets formulated with commonly used excipients (microcrystalline
Heikki O Koskela et al.
Chest, 124(6), 2171-2177 (2003-12-11)
To compare a new bronchial provocation test, the mannitol challenge, with cold air and histamine challenges to demonstrate airway hyperresponsiveness (AHR) in patients with difficult-to-diagnose asthma. A prospective study. Thirty-seven consecutive patients with recently diagnosed, steroid-naive, mild, or atypical asthma
Heikki O Koskela et al.
Chest, 125(6), 1985-1992 (2004-06-11)
To define whether coughing during mannitol challenge is a nonspecific side effect of this challenge or is associated with asthma. A prospective study. University hospital. Thirty-seven steroid-naive, asthmatic subjects and 10 healthy subjects. The participants completed a symptom questionnaire, recorded
Heikki O Koskela et al.
Chest, 124(4), 1341-1349 (2003-10-14)
To compare the sensitivity and validity of mannitol, histamine, and cold air challenges to demonstrate the effect of inhaled corticosteroids (ICS) in asthma. A prospective study. Seventeen patients with recently diagnosed, steroid-naive asthma who fulfilled the diagnostic criteria of Finnish
Diana Bilton et al.
Thorax, 69(12), 1073-1079 (2014-09-24)
Bronchiectasis is characterised by excessive production of mucus and pulmonary exacerbations. Inhaled osmotic agents may enhance mucociliary clearance, but few long-term clinical trials have been conducted. To determine the impact of inhaled mannitol on exacerbation rates in patients with non-cystic
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）